Alaunos Therapeutics, Inc. (TCRT) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts TCRT Hot Sheet
Join SI Premium – FREE
Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $0 .
For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox gains on strong earnings and revenue beat
- Teladoc (TDOC) PT Raised to $11 at Piper Sandler
- Bloomin' Brands (BLMN) PT Raised to $11.50 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
